Regeneron Pharmaceuticals (REGN)
Operating Income Growth
3.36%
TTM · Period ending:
REGN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported3.36%period ending
Latest reported3.36%period ending
REGN TTM Operating Income YoY % (-87.88% → 3.36%)
Year-over-year change
High-resolution chart · PNG
REGN operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -92.1958% | |
| -51.8659% | |
| 5.1528% | |
| 33.7153% | |
| -23.9344% | |
| -92.1875% | |
| -457.4074% | |
| -568.2927% | |
| -115.2941% | |
| -66.2338% | |
| 59.7015% | |
| 75.4491% | |
| 49.1018% | |
| 55.4913% | |
| 13.5484% | |
| -23.7037% | |
| -50.4505% | |
| -127.6316% | |
| -55% | |
| -19.469% | |
| 44.5% | |
| 73.9726% | |
| 71.6714% | |
| 72.3716% | |
| 50.86% | |
| 26.0759% | |
| -2.6163% | |
| -33.2248% | |
| -66.8033% | |
| -114.6739% | |
| -115% | |
| -137.9845% | |
| -114.0351% | |
| -196.7742% | |
| -68.4211% | |
| -126.3158% | |
| -356% | |
| -87.8788% |